About: Effect of serum parathyroid hormone and bone marrow fibrosis on the response to erythropoietin in uremia

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Effect of serum parathyroid hormone and bone marrow fibrosis on the response to erythropoietin in uremia Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 January 1993

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в січні 1993 (uk) im Januar 1993 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en xineru de 1993 (ast) artikull shkencor i botuar më 01 janar 1993 (sq) scientific article published on 01 January 1993 (en)
publication date	wds:Q70522678-D38C6FBA-125F-4B12-AE0C-0E7124F25562
publication date	1993-01-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q70522678-2CAE32B2-7D02-411F-9C4C-C3F969961D2D
language of work or name	English
author name string	wds:Q70522678-DA60D261-4003-487C-B2DF-658ABE7484D0 wds:Q70522678-DECDD43F-5998-4DA7-8119-C2C96F54203D wds:Q70522678-EF36F04F-486C-417A-900E-93064B801FBB
author name string	Rao DS Shih MS Mohini R
rdfs:label	Effect of serum parathyroid hormone and bone marrow fibrosis on the response to erythropoietin in uremia (en) Effect of serum parathyroid hormone and bone marrow fibrosis on the response to erythropoietin in uremia (nl) Effect of serum parathyroid hormone and bone marrow fibrosis on the response to erythropoietin in uremia (sq)
skos:prefLabel	Effect of serum parathyroid hormone and bone marrow fibrosis on the response to erythropoietin in uremia (en) Effect of serum parathyroid hormone and bone marrow fibrosis on the response to erythropoietin in uremia (nl) Effect of serum parathyroid hormone and bone marrow fibrosis on the response to erythropoietin in uremia (sq)
name	Effect of serum parathyroid hormone and bone marrow fibrosis on the response to erythropoietin in uremia (en) Effect of serum parathyroid hormone and bone marrow fibrosis on the response to erythropoietin in uremia (nl) Effect of serum parathyroid hormone and bone marrow fibrosis on the response to erythropoietin in uremia (sq)
title	wds:Q70522678-A25199F6-83DF-4E9D-8133-1D6E788989C7
title	Effect of serum parathyroid hormone and bone marrow fibrosis on the response to erythropoietin in uremia (en)
page(s)	wds:Q70522678-2B2E3FCA-246C-46D2-99F8-DB02886B88B0
page(s)	171-175
instance of	wds:Q70522678-0A6FACF4-05FA-4506-9EBF-4CD41487CA08
instance of	scholarly article
main subject	wds:Q70522678-731078DA-1BC8-49E4-B7C7-56D52618A2D9
main subject	uremia
PubMed ID	wds:Q70522678-3C1327D1-AD4B-428F-AEAA-0E0C1080720A
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/8417383
PubMed ID	8417383
published in	wds:Q70522678-730E4D3C-9710-4280-A38E-E4771F90A571
published in	The New England Journal of Medicine
issue	wds:Q70522678-2840344A-9440-4B1D-8124-004B60125EEE
volume	wds:Q70522678-E54E78F3-F196-4F4B-8484-261D9678ECB9
issue	3
volume	328
DOI	wds:Q70522678-9C5D2B19-60F2-41B2-BFE6-BE50784AD053
DOI	http://dx.doi.org/10.1056/NEJM199301213280304
DOI	10.1056/NEJM199301213280304
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q70522678
is cites work of	The association between parathyroid hormone and mortality in dialysis patients is modified by wasting IV. NKF-K/DOQI Clinical Practice Guidelines for Anemia of Chronic Kidney Disease: update 2000 Vitamin D deficiency and anemia in early chronic kidney disease Predictors of hyporesponsiveness to erythropoiesis-stimulating agents in hemodialysis patients Controversies in selection of epoetin dosages. Issues and answers Bone and mineral disorders in pre-dialysis CKD. Secondary hyperparathyroidism is associated with higher mortality in men with moderate to severe chronic kidney disease. Would artificial neural networks implemented in clinical wards help nephrologists in predicting epoetin responsiveness? Erythropoietin in the pathogenesis and treatment of the anemia of chronic renal failure Use of vitamin D in chronic kidney disease patients Erythropoietin in chronic renal failure Considerations for optimal iron use for anemia due to chronic kidney disease Iron management in end-stage renal disease Secondary hyperparathyroidism and brown tumor in dialyzed patients Severity of AIDS and the response to EPO in uremia Role of type of vascular access in erythropoietin and intravenous iron requirements in haemodialysis. A novel population of cells expressing both hematopoietic and mesenchymal markers is present in the normal adult bone marrow and is augmented in a murine model of marrow fibrosis Naturally occurring higher hemoglobin concentration does not increase mortality among hemodialysis patients Vitamin D receptor activation and survival in chronic kidney disease. A 6-month study of low-dose recombinant human erythropoietin alone and in combination with androgens for the treatment of anemia in chronic hemodialysis patients Mice lacking the sodium-dependent phosphate import protein, PiT1 (SLC20A1), have a severe defect in terminal erythroid differentiation and early B cell development Ergocalciferol decreases erythropoietin resistance in children with chronic kidney disease stage 5. Elderly patients on chronic hemodialysis with hyperparathyroidism: increase of hemoglobin level after intravenous calcitriol. The effect of calcitriol on renal anaemia in patients undergoing long-term dialysis Risk for anemia in pediatric chronic kidney disease patients: a report of NAPRTCS. PTH and stem cells Use of agents stimulating erythropoiesis in digestive diseases Clinical application of recombinant erythropoietin in renal dialysis patients. Posttransplant erythrocytosis: an enigma revisited Optimal care of the pediatric end-stage renal disease patient on dialysis Recurrent nonsuppressible secondary hyperparathyroidism following subtotal parathyroidectomy. Anemia in children with chronic kidney disease Resistance of dialyzed patients to erythropoietin Resistance to recombinant erythropoietin in a hemodialysis patient with heterozygous hemoglobinopathy J-Meinung Iron metabolism in hemodialyzed patients - a story half told? Parathyroid hormone may be an early predictor of low serum hemoglobin concentration in patients with not advanced stages of chronic kidney disease. Association of vitamin D deficiency and hyperparathyroidism with anemia: a cross-sectional study Hyporesponsiveness to erythropoiesis-stimulating agent as a prognostic factor in Japanese hemodialysis patients: the Q-Cohort study [Iron supplementation in preterm infants treated with erythropoietin] Poor response to erythropoietin The case for routine parathyroid hormone monitoring Management of anemia in children receiving chronic peritoneal dialysis Effects of Parathyroidectomy on Iron Homeostasis and Erythropoiesis in Hemodialysis Patients with Severe Hyperparathyroidism Elderly patients on chronic hemodialysis: effect of the secondary hyperparathyroidism on the hemoglobin level Anemia in chronic kidney disease. Osteoprotegerin abrogated cortical porosity and bone marrow fibrosis in a mouse model of constitutive activation of the PTH/PTHrP receptor Lack of hepcidin ameliorates anemia and improves growth in an adenine-induced mouse model of chronic kidney disease Obesity may be erythropoietin dose-saving in hemodialysis patients. Thresholds of iron markers for iron deficiency erythropoiesis-finding of the Japanese nationwide dialysis registry Low-dose subcutaneous recombinant erythropoietin in children with chronic renal failure. Australian and New Zealand Paediatric Nephrology Association Relationship between serum phosphorus levels and various outcome measures in adult hemodialysis patients Early effects of parathyroidectomy on erythropoietin production in secondary hyperparathyroidism Is There a Gender Difference in Clinical Presentation of Renal Hyperparathyroidism and Outcome after Parathyroidectomy?

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 196 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software